Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

720 ARTÍCULOS , VIENDO DEL 241 AL 255

The neuroinflammatory role of microglia in Alzheimer's disease and their associated therapeutic targets

AmeliMojarad M, AmeliMojarad M.

CNS Neurosci Ther. 2024 Jul;30(7):e14856. doi: 10.1111/cns.14856.

Natural products targeting amyloid-β oligomer neurotoxicity in Alzheimer's disease

Gonçalves PB, Sodero ACR, Cordeiro Y.

Eur J Med Chem. 2024 Oct 5;276:116684. doi: 10.1016/j.ejmech.2024.116684. Epub 2024 Jul 14.

Mesenchymal stem cell therapy for Alzheimer's disease: A novel therapeutic approach for neurodegenerative diseases

Bhatt A, Bhardwaj H, Srivastava P.

Neuroscience. 2024 Sep 13;555:52-68. doi: 10.1016/j.neuroscience.2024.07.019. Epub 2024 Jul 19.

Evolving significance of kinase inhibitors in the management of Alzheimer's disease

Ansari MM, Sahu SK, Singh TG, Singh SRJ, Kaur P.

Eur J Pharmacol. 2024 Sep 15;979:176816. doi: 10.1016/j.ejphar.2024.176816. Epub 2024 Jul 20.

Advances in Understanding and Managing Alzheimer's Disease: From Pathophysiology to Innovative Therapeutic Strategies

Rathee S, Sen D, Pandey V, Jain SK.

Curr Drug Targets. 2024;25(11):752-774. doi: 10.2174/0113894501320096240627071400.

Change in Digital Cognitive Test Performance between Solanezumab and Placebo Groups in Preclinical Alzheimer's Disease: Secondary Analyses from the A4 Study

Papp KV, Maruff P, Rentz DM, Donohue MC, Liu A, Aisen PS, Sperling RA.

J Prev Alzheimers Dis. 2024;11(4):846-856. doi: 10.14283/jpad.2024.137.

Safety, Efficacy and Clinical Applications of Focused Ultrasound-Mediated Blood Brain Barrier Opening in Alzheimer's Disease: A Systematic Review

Patwardhan A, Wilkinson T, Meng Y, Alhashyan I, Black SE, Lipsman N, Masellis M.

J Prev Alzheimers Dis. 2024;11(4):975-982. doi: 10.14283/jpad.2024.85.

Epigenetic Mechanisms of Aluminum-Induced Neurotoxicity and Alzheimer's Disease: A Focus on Non-Coding RNAs

Aschner M, Skalny AV, Santamaria A, Rocha JBT, Mansouri B, Tizabi Y, Madeddu R, Lu R, Lee E, Tinkov AA.

Neurochem Res. 2024 Nov;49(11):2988-3005. doi: 10.1007/s11064-024-04214-9. Epub 2024 Jul 27.

Targeting Microglia in Alzheimer's Disease: Pathogenesis and Potential Therapeutic Strategies

Sun Z, Zhang X, So KF, Jiang W, Chiu K.

Biomolecules. 2024 Jul 11;14(7):833. doi: 10.3390/biom14070833.

Towards multicenter β-amyloid PET imaging in mouse models: A triple scanner head-to-head comparison

Gnörich J, Koehler M, Wind-Mark K, Klaus C, Zatcepin A, Palumbo G, Lalia M, Monasor LS, Beyer L, Eckenweber F, Scheifele M, Gildehaus FJ, von Ungern-Sternberg B, Barthel H, Sabri O, Bartenstein P, Herms J, Tahirovic S, Franzmeier N, Ziegler S, Brendel M.

Neuroimage. 2024 Aug 15;297:120748. doi: 10.1016/j.neuroimage.2024.120748. Epub 2024 Jul 26.

Emerging role of Metformin in Alzheimer's disease: A translational view

Ríos JA, Bórquez JC, Godoy JA, Zolezzi JM, Furrianca MC, Inestrosa NC.

Ageing Res Rev. 2024 Sep;100:102439. doi: 10.1016/j.arr.2024.102439. Epub 2024 Jul 27.

How to address the complexity of multi-targeted drug discovery for Alzheimer's disease?

González JF, Sánchez-Montero JM.

Expert Opin Drug Discov. 2024 Oct;19(10):1149-1152. doi: 10.1080/17460441.2024.2385576. Epub 2024 Jul 29.

Aducanumab: A look two years after its approval

Torres A, Camargo L, López N.

Biomedica. 2024 May 31;44(Sp. 1):42-46. doi: 10.7705/biomedica.6967.

Revolutionizing neurotherapeutics: Nanocarriers unveiling the potential of phytochemicals in Alzheimer's disease

Kamath AP, Nayak PG, John J, Mutalik S, Balaraman AK, Krishnadas N.

Neuropharmacology. 2024 Nov 15;259:110096. doi: 10.1016/j.neuropharm.2024.110096. Epub 2024 Jul 29.

Comparing regional brain uptake of incretin receptor agonists after intranasal delivery in CD-1 mice and the APP/PS1 mouse model of Alzheimer's disease

Abdulhameed N, Babin A, Hansen K, Weaver R, Banks WA, Talbot K, Rhea EM.

Alzheimers Res Ther. 2024 Aug 1;16(1):173. doi: 10.1186/s13195-024-01537-1.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias